Search Legislation

Council Directive of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine (64/432/EEC)

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Status:

EU Directives are published on this site to aid cross referencing from UK legislation. Since IP completion day (31 December 2020 11.00 p.m.) no amendments have been applied to this version.

[F1CHAPTER II U.K. TESTS FOR ENZOOTIC BOVINE LEUKOSIS

Tests for enzootic bovine leukosis shall be carried out by the immune-diffusion test under the conditions described in A and B or by the enzyme-linked immunosorbent assay (Elisa) under the conditions described in C. The immune-diffusion method may only be used for individual tests. If test results are the subject of a duly-substantiated challenge, an additional check shall be carried out by means of the immune-diffusion test.

A. Agar gel immune-diffusion test for enzootic bovine leukosis U.K.

[F2 [F31. The antigen to be used in the test must contain bovine leukosis virus glycoproteins. The antigen must be standardised against a standard serum (EI serum) supplied by the National Veterinary Institute, Technical University of Denmark, Copenhagen V.] U.K.
2. [F3The official institutes indicated below must be responsible for calibrating the standard working antigen of the laboratory against the official EEC standard serum (EI serum) supplied by the National Veterinary Institute, Technical University of Denmark, Kalvehave.] U.K.
AT

AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection-Institute for veterinary investigations Mödling)

Robert Koch-Gasse 17

A-2340 Mödling

Tel.: +43 (0) 505 55-38112

Fax: +43 (0) 505 55-38108

E-mail: vetmed.moedling@ages.at

BE

CODA — CERVA — VAR

Veterinary and Agrochemical Research Centre

Groeselenberg 99

B-1180 Brussels

[F4BG

Национален диагностичен научноизследователски ветеринарномедицински институт, Проф. д-р Георги Павлов, бул. Пенчо Славейков 15, София 1606

(National Diagnostic Veterinary Research Institute Prof. Dr. Georgi Pavlov, 15, Pencho Slaveykov Blvd., 1606 Sofia)]

CY

State Veterinary Laboratory

Veterinary Services

1417 Athalassa

Nicosia

CZ

Státní veterinární ústav

Praha – Lysolaje

Sídlištní 136/24

165 03 Praha 6 – Lysolaje

[F3DE

Friedrich-Loeffler-Institut

Bundesforschungsinstitut für Tiergesundheit

Standort Wusterhausen

Seestraße 55

16868 Wusterhausen

Tel. (49-33979) 80-0

Fax (49-33979) 80-200

E-Mail: poststelle.wus@fli.bund.de

DK

National Veterinary Institute, Technical University of Denmark

Lindholm

DK-4771 Kalvehave]

EE

Veterinaar- ja Toidulaboratoorium

Kreutzwaldi 30, 51006 Tartu, Estonia

Tel.: +372 7 386 100

Faks: +372 7 386 102

E-post: info@vetlab.ee

ES

Laboratorio Central de Sanidad Animal de Algete

Carretera de Algete, km 8

Algete 28110 (Madrid)

Tel.: +34 916 290 300

Fax: +34 916 290 598

E-mail: lcv@mapya.es

FI

Finnish Food Safety Authority

Animal Diseases and Food Safety Research

Mustialankatu 3

FI-00790 Helsinki, Finland

E-mail: info@evira.fi

Tel.: +358 20 772 003 (exchange)

Fax: +358 20 772 4350

FR

Laboratoire d’études et de recherches en pathologie bovine et hygiène des viandes

AFSSA site de Lyon — LERPBHV

31 avenue Tony Garnier

69364 Lyon Cedex 07 FRANCE

GB

Veterinary Laboratories Agency

New Haw, Addlestone, Weybridge

Surrey KT15 3NB, UK

Tel. (44-1932) 341111

Fax (44-1932) 347046

Immunodiagnostics Department

Veterinary Sciences Division

Stoney Road Stormont

Belfast BT4 3SD, UK

GR

Hellenic Ministry of Rural Development and Food

Centre of Athens Veterinary Institutions

Institute of Foot and Mouth Disease and exotic diseases

25 Neapoleos Street

15 310 Ag. Paraskevi

Tel.: + 30 210 6010903-6007016

Fax: + 30 210 6399477

[F3HU

Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság

Central Agricultural Office, Veterinary Diagnostic Directorate

Address: 1149 Budapest, Tábornok u. 2.

Mailing Address: 1581 Budapest, 146. Pf. 2.

Tel.: +36 1 460-6300

Fax: +36 1 252-5177

E-mail: titkarsag@oai.hu]

IE

Virology Division

Central Veterinary Research Laboratory

Department of Agriculture and Food Laboratories

Backweston Campus

Stacumny Lane

Celbridge

Co. Kildare

IT

Centro di referenza nazionale per i retrovirus correlati alle patologie infettive dei ruminanti c/o Istituto zooprofilattico sperimentale dell’ Umbria e delle Marche,

Via G. Salvemini 1,

06126 Perugia

Tel. +39 75 3431

Fax +39 75 35047

LT

Nacionalinė veterinarijos laboratorija,

J. Kairiūkščio g. 10,

LT-2021 Vilnius

LU

CODA — CERVA — VAR

Veterinary and Agrochemical Research Centre

Groeselenberg 99

B-1180 Brussels

LV

Nacionālais diagnostikas centrs

(National Diagnostic Centre)

Lejupes iela 3, Rīga, LV-1076

Tel.: +371 7620526

Fax: +371 7620434

E-mail: ndc@ndc.gov.lv

MT
NL

Centraal Instituut voor DierziekteControle

CIDC-Lelystad

Hoofdvestiging: Houtribweg 39

Nevenvestiging: Edelhertweg 15

Postbus 2004

8203 AA Lelystad

PL

Laboratory Departament of Biochemistry

Państwowy Instytut Weterynaryjny – Państwowy Instytut Badawczy,

Al. Partyzantów 57, 24-100 Puławy

Tel.: +48.81.886 30 51

Fax: +48.81.886 25 95

E-mail: sekretariat@piwet.pulawy.pl

PT

Laboratório Nacional de Investigação Veterinária (LNIV)

Estrada de Benfica, 701

P-1549-011 Lisboa

[F4RO

Institutul de Diagnostic și Sănătate Animală

Strada Dr. Staicovici nr. 63, sector 5

codul 050557, București]

SE

Statens Veterinärmedicinska Anstalt

SE-751 89 Uppsala

SI

Univerza v Ljubljani

Veterinarska fakulteta

Nacionalni veterinarski inštitut

Gerbičeva 60,

SI-1000 Ljubljana

SK

Štátny veterinárny ústav

Pod dráhami 918

SK-960 86 Zvolen]

3. The standard antigens used in the laboratory must be submitted at least once a year to the EEC reference laboratories listed in 2 for testing against the official EEC standard serum. Apart from this standardization, the antigen in use can be calibrated in accordance with B. U.K.
4. The reagents for the test shall consist of: U.K.
(a)

antigen: the antigen must contain specific glycoproteins of enzootic bovine leukosis virus which has been standardized against the official EEC serum;

(b)

the test serum;

(c)

known positive control serum;

(d)

agar gel:

  • 0,8 % agar,

  • 8,5 % NaCl,

  • 0,05 M Tris-buffer pH 7,2;

15 ml of this agar must be introduced into a petri dish of 85 mm diameter, resulting in a depth of 2,6 mm of agar.

5. A test pattern of seven moisture-free wells must be cut in the agar to the bottom of the plate; the pattern must consist of one central well and six wells in a circle around it. U.K.

Diameter of central well: 4 mm

Diameter of peripheral wells: 6 mm

Distance between central and peripheral wells: 3 mm

6. The central well must be filled with the standard antigen. Peripheral wells 1 and 4 (see diagram below) are filled with the known positive serum, wells 2, 3, 5 and 6 with the test sera. The wells must be filled until the meniscus disappears. U.K.
7. This results in the following quantities being obtained: U.K.
  • antigen: 32 μl

  • control serum: 73 μl

  • test serum: 73 μl.

8. Incubation must be for 72 hours at room temperature (20 to 27 o C) in a closed humid chamber. U.K.
9. The test may be read at 24 and 48 hours but a final result may not be obtained before 72 hours: U.K.
(a)

a test serum is positive if it forms a specific precipitin line with the BLV antigen and forms a complete line of identity with the control serum;

(b)

a test serum is negative if it does not form a specific precipitin line with the BLV antigen and if it does not bend the line of the control serum;

(c)

the reaction cannot be considered conclusive if it:

(i)

bends the line of the control serum towards the BLV antigen well without forming a visible precipitin line with the antigen;

or

(ii)

if it cannot be read either as negative or as positive.

In inconclusive reactions the test may be repeated and concentrated serum utilized.

10. Any other well configuration or pattern may be utilized provided that the E4 serum diluted 1:10 in negative serum can be detected as positive. U.K.

B. Method for antigen standardization U.K.

Solutions and materials required U.K.
1. 40 ml of 1,6 % agarose in 0,05 M Tris/HCl buffer, pH 7,2 with 8,5 % NaCl; U.K.
2. 15 ml of a bovine leukosis serum, having antibody only to bovine leukosis virus glycoproteins, diluted 1:10 in 0,05 M Tris/HCl buffer, pH 7,2 with 8,5 % NaCl; U.K.
3. 15 ml of a bovine leukosis serum, having antibody only to bovine leukosis virus glycoproteins, diluted 1:5 in 0,05 M Tris/HCl buffer, pH 7,2 with 8,5 % NaCl; U.K.
4. four plastic petri dishes with a diameter of 85 mm; U.K.
5. a punch with a diameter of 4 to 6 mm; U.K.
6. a reference antigen; U.K.
7. the antigen which is to be standardized; U.K.
8. a water bath (56 o C). U.K.
Procedure U.K.

Dissolve the agarose (1,6 %) in the Tris/HCl buffer by carefully heating to 100 o C. Place in 56 o C water bath for approximately one hour. Also, place the bovine leukosis serum dilutions in a 56 o C water bath.

Now mix 15 ml of the 56 o C agarose solution with the 15 ml bovine leukosis serum (1:10), quickly shake and pour 15 ml into each of two petri dishes. Repeat this procedure with the bovine leukosis serum diluted 1:5.

When the agarose has hardened, holes are made in it as follows:

Addition of antigen U.K.
(i)

Petri dishes 1 and 3:

  • well A — undiluted reference antigen,

  • well B — 1:2 diluted reference antigen,

  • wells C and E — reference antigen,

  • well D — undiluted test antigen.

(ii)

Petri dishes 2 and 4:

  • well A — undiluted test antigen,

  • well B — 1:2 diluted test antigen,

  • well C — 1:4 diluted test antigen,

  • well D — 1:8 diluted test antigen.

Additional instructions U.K.
1. The experiment shall be carried out with two serum dilutions (1:5 and 1:10) in order to achieve optimal precipitation U.K.
2. If the precipitation diameter is too small with both dilutions, then the serum must be further diluted. U.K.
3. If the precipitation diameter in both dilutions is too large and faint, then a lower serum must be chosen. U.K.
4. The final concentration of the agarose must be 0,8 %; that of the sera 5 and 10 % respectively. U.K.
5. Plot the measured diameters in the following coordinate system. The dilution of the antigen to be tested with the same diameter as the reference antigen is the working dilution. U.K.

C. Enzyme-linked immunosorbent assay (Elisa) for detecting enzootic bovine leukosis U.K.

1. The material and reagents to be used are as follows: U.K.
(a)

solid-phase microplates, cuvettes or any other solid phase;

(b)

the antigen is fixed to the solid phase with or without the aid of polyclonal or monoclonal catching antibodies. If antigen is coated directly to the solid phase, all test samples giving positive reactions have to be retested against control antigen in the case of EBL. The control antigen should be identical to the antigen except for the BLV antigens. If catching antibodies are coated to the solid phase, the antibodies must not react to antigens other than BLV antigens;

(c)

the biological fluid to be tested;

(d)

a corresponding positive and negative control;

(e)

conjugate;

(f)

a substrate adapted to the enzyme used;

(g)

a stopping solution, if necessary;

(h)

solutions for the dilution of the test samples for preparations of the reagents and for washing;

(i)

a reading system appropriate to the substrate used.

2. Standardization and sensitivity of test U.K.

The sensitivity of the Elisa assay must be of such a level that E4 serum is scored positive when diluted 10 times (serum samples) or 250 times (milk samples) more than the dilution obtained of individual samples when these are included in pools. In assays where samples (serum and milk) are tested individually E4 serum diluted 1 to 10 (in negative serum) or 1 to 250 (in negative milk) must be scored positive when tested in the same assay dilution as used for the individual test samples. The official institutes listed in A.2 will be responsible for checking the quality of the Elisa method, and in particular for determining, for each production batch, the number of samples to be pooled on the basis of the count obtained for the E4 serum.

The E4 serum will be supplied by the National Veterinary Laboratory, Copenhagen.

3. Conditions for use of the Elisa test for EBL U.K.

The Elisa method may be used on a sample of milk or whey taken from the milk collected from a farm with at least 30 % of dairy cows in milk.

If this method is used, measures must be taken to ensure that the samples taken can be identified with the animals from which the milk or sera examined were taken.]

Back to top

Options/Help

Print Options

You have chosen to open the Whole Directive

The Whole Directive you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open Schedules only

The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources